Quantcast

Suit: Theranos falsely advertised accuracy of blood tests

NORTHERN CALIFORNIA RECORD

Sunday, December 22, 2024

Suit: Theranos falsely advertised accuracy of blood tests

General court 09

shutterstock.com

SAN FRANCISCO – An Arizona man claims a Palo Alto company falsely advertised the accuracy of its blood tests.

Brian Maltese filed a complaint on behalf of all others similarly situated on June 17 in the U.S. District Court for the Northern District of California against Theranos Inc. alleging unjust enrichment, violation of state consumer laws and other counts.

According to the complaint, the plaintiff alleges that he suffered damages and may have placed his health at risk as a result of inaccurate blood test from the defendant. The plaintiff holds Theranos Inc. responsible because the defendant allegedly claims that its blood testing kits offer 100 percent accurate results but was later determined that it does not, which could purportedly cause serious health risks to consumers that rely on its product to check their blood.

The plaintiff requests a trial by jury and seeks enjoin the defendant, cost, restitution, all damages, disgorgement, interest, all legal fees and any other relief as the court deems just. He is represented by Shana E. Scarlett, Robert B. Carey, Leonard Aragon and Steve W. Berman of Hagens Berman Sobol Shapiro LLP in Berkeley, Seattle and Phoenix.

U.S. District Court for the Northern District of California Case number 5:16-cv-03418

More News